UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long‐term follow‐up of chronic hepatitis C patients with sustained virological response to various forms of interferon‐based anti‐viral therapy

Alimentary pharmacology & therapeutics, 2006-02, Vol.23 (4), p.507-511

2006

Volltextzugriff (PDF)

798 VERY EARLY VIRAL KINETICS ON INTERFERON TREATMENT IN CHRONIC HEPATITIS C VIRUS GENOTYPE 4 INFECTION

Journal of hepatology, 2008, Vol.48, p.S298-S298

2008

Volltextzugriff (PDF)

Short‐ and long‐term effects of therapy with interferon‐α and pegylated interferon‐α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2005-01, Vol.21 (1), p.49-55

2005

Volltextzugriff (PDF)

Comparison of the Bayer VERSANT HCV RNA 3.0 and the Roche COBAS Amplicor HCV Monitor, Version 2.0, assays in HCV genotype 4 infection

Journal of viral hepatitis, 2007-11, Vol.14 (11), p.775-781

2007

Volltextzugriff (PDF)

Morphodynamic river processes and techniques for assessment of channel evolution in Alpine gravel bed rivers

Geomorphology (Amsterdam, Netherlands), 2007-10, Vol.90 (3), p.340-355

2007

Volltextzugriff (PDF)

Twice-weekly administration of peginterferon-α-2b improves viral kinetics in patients with chronic hepatitis C genotype 1

Journal of viral hepatitis, 2003-07, Vol.10 (4), p.271-276

2003

Volltextzugriff (PDF)

Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1

Journal of viral hepatitis, 2003-07, Vol.10 (4), p.271-276

2003

Volltextzugriff (PDF)

Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection

Journal of hepatology, 2006-02, Vol.44 (2), p.275-282

2006

Volltextzugriff (PDF)

Tongue and Skin Hyperpigmentation During PEG-Interferon-α/Ribavirin Therapy in Dark-Skinned Non-Caucasian Patients with Chronic Hepatitis C

The American journal of gastroenterology, 2006-01, Vol.101 (1), p.197-198

2006

Volltextzugriff (PDF)

Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection

AIDS (London), 2005-10, Vol.19 Suppl 3 (Suppl 3), p.S85-S92

2005

Volltextzugriff (PDF)

Lansoprazol-assoziierte eosinophile Colitis

Zeitschrift für Gastroenterologie, 2007, Vol.44 (7)

2007

Volltextzugriff (PDF)

Prospective study of viral clearance and CD4 + T-cell response in acute hepatitis C primary infection and reinfection

Journal of clinical virology, 2006-05, Vol.36 (1), p.24-31

2006

Volltextzugriff (PDF)

Successful Treatment of Chronic Hepatitis D with a Short Course of Peginterferon alfa-2a

The American journal of gastroenterology, 2005-07, Vol.100 (7), p.1626-1627

2005

Volltextzugriff (PDF)

Morphodynamic river processes and techniques for assessment of channel evolution in Alpine gravel bed rivers: Reduced-complexicity geomorphological modelling for river and catchment management

Geomorphology (Amsterdam, Netherlands), 2007, Vol.90 (3-4), p.340-355

2007

Volltextzugriff (PDF)

Sudden Hearing Loss in Patients with Chronic Hepatitis C Treated with Pegylated Interferon Ribavirin

The American journal of gastroenterology, 2004-05, Vol.99 (5), p.873-877

2004

Volltextzugriff (PDF)

Antiviral therapy decreases GpIIb/IIIa activation of platelets in patients with chronic hepatitis C

Thrombosis and haemostasis, 2006-02, Vol.95 (2), p.260-266

2006

Volltextzugriff (PDF)

419 Apoptosis combined with virus load on day 1 of IFN treatment as a predictive marker of response to IFN therapy of chronic hepatitis C

Journal of hepatology, 2006-04, Vol.44, p.S157-S157

2006

Volltextzugriff (PDF)

Einfluss der Therapie mit pegyliertem Interferon-α auf die Thrombozytenfunktion und von Willebrand Faktor Freisetzung bei Patienten mit chronischer Hepatitis C

Zeitschrift für Gastroenterologie, 2004, Vol.42 (5)

2004

Volltextzugriff (PDF)

The Impact of Positive Peritoneal Washings and Serosal and Adnexal Involvement on Survival in Patients with Stage IIIA Uterine Cancer

Gynecologic oncology, 2002-09, Vol.86 (3), p.269-273

2002

Volltextzugriff (PDF)

Short- and long-term effects of therapy with interferon-a and pegylated interferon-α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2005, Vol.21 (1), p.49-55

2005

Volltextzugriff (PDF)

Hepatitis C viral dynamics: basic concept and clinical significance

Journal of Clinical Virology, 2002-12, Vol.25 (S3), p.31-39

2002

Volltextzugriff (PDF)

Interferon sensitivity in chronic hepatitis C virus genotype 4 infection

Journal of hepatology, 2003-04, Vol.38, p.147-148

2003

Volltextzugriff (PDF)

476 Prospective evaluation of the 24 hour interferon (IFN) induced decline in hepatitis C virus genotype 1 load to predict sustained virologic response (SVR) to peginterferon-Alfa2A/ribavirin combination therapy with or without amantadine

Journal of hepatology, 2004, Vol.40, p.141-141

2004

Volltextzugriff (PDF)

Akute Hepatitis B-Infektion unter Kombinationstherapie mit (PEG-)Interferon-alpha und Ribavirin bei Patienten mit chronischer Hepatitis C

Zeitschrift für Gastroenterologie, 2005-05, Vol.43 (5)

2005

Volltextzugriff (PDF)

989 Genetic variations of interferon activation have no effect on response to antiviral therapy in chronic hepatitis C-genotype 1

Hepatology (Baltimore, Md.), 2003, Vol.38, p.632-632

2003

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(28)

Publikationsform

Sprache

Englisch
(33)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Humans
(15)
Life Sciences & Biomedicine
(15)
Adult
(12)
Female
(12)
Biological And Medical Sciences
(11)
Infectious Diseases
(11)
Medical Sciences
(11)
Male
(10)
Middle Aged
(10)
Recombinant Proteins
(10)
Gastroenterology & Hepatology
(8)
Hepatitis C, Chronic - Drug Therapy
(8)
Human Viral Diseases
(8)
Interferon-Alpha - Therapeutic Use
(8)
Viral Diseases
(8)
Viral Hepatitis
(8)
Drug Therapy, Combination
(7)
Hepatitis C Virus
(7)
Polyethylene Glycols - Therapeutic Use
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long‐term follow‐up of chronic hepatitis C patients with sustained virological response to various forms of interferon‐based anti‐viral therapy

798 VERY EARLY VIRAL KINETICS ON INTERFERON TREATMENT IN CHRONIC HEPATITIS C VIRUS GENOTYPE 4 INFECTION

Short‐ and long‐term effects of therapy with interferon‐α and pegylated interferon‐α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C

Comparison of the Bayer VERSANT HCV RNA 3.0 and the Roche COBAS Amplicor HCV Monitor, Version 2.0, assays in HCV genotype 4 infection

Morphodynamic river processes and techniques for assessment of channel evolution in Alpine gravel bed rivers

Twice-weekly administration of peginterferon-α-2b improves viral kinetics in patients with chronic hepatitis C genotype 1

Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1

Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection

Tongue and Skin Hyperpigmentation During PEG-Interferon-α/Ribavirin Therapy in Dark-Skinned Non-Caucasian Patients with Chronic Hepatitis C

Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection

Lansoprazol-assoziierte eosinophile Colitis

Prospective study of viral clearance and CD4 + T-cell response in acute hepatitis C primary infection and reinfection

Successful Treatment of Chronic Hepatitis D with a Short Course of Peginterferon alfa-2a

Morphodynamic river processes and techniques for assessment of channel evolution in Alpine gravel bed rivers: Reduced-complexicity geomorphological modelling for river and catchment management

Sudden Hearing Loss in Patients with Chronic Hepatitis C Treated with Pegylated Interferon Ribavirin

Antiviral therapy decreases GpIIb/IIIa activation of platelets in patients with chronic hepatitis C

419 Apoptosis combined with virus load on day 1 of IFN treatment as a predictive marker of response to IFN therapy of chronic hepatitis C

Einfluss der Therapie mit pegyliertem Interferon-α auf die Thrombozytenfunktion und von Willebrand Faktor Freisetzung bei Patienten mit chronischer Hepatitis C

The Impact of Positive Peritoneal Washings and Serosal and Adnexal Involvement on Survival in Patients with Stage IIIA Uterine Cancer

Short- and long-term effects of therapy with interferon-a and pegylated interferon-α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C

Hepatitis C viral dynamics: basic concept and clinical significance

Interferon sensitivity in chronic hepatitis C virus genotype 4 infection

476 Prospective evaluation of the 24 hour interferon (IFN) induced decline in hepatitis C virus genotype 1 load to predict sustained virologic response (SVR) to peginterferon-Alfa2A/ribavirin combination therapy with or without amantadine

Akute Hepatitis B-Infektion unter Kombinationstherapie mit (PEG-)Interferon-alpha und Ribavirin bei Patienten mit chronischer Hepatitis C

989 Genetic variations of interferon activation have no effect on response to antiviral therapy in chronic hepatitis C-genotype 1

Suchergebnisse filtern